The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
American Association of Clinical Endocrinologists Medical Guidelines For Clinical Practice For The Prevention and Treatment of Postmenopausal Osteoporosis: 2001 Edition, With Selected Updates For 2003
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, R. W., Dequeker, J., Favus, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,288
Self-citationEffect of Risedronate on the Risk of Hip Fracture in Elderly Women
McClung, M. R., Geusens, P., Miller, P. D., Zippel, H., Bensen, W. G., Roux, C., Adami, S., Fogelman, I., Diamond, T., Eastell, R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440503 · Cited by 1,918
Self-citationCummings, S. R., Eckert, S., Krueger, K. A., Grady, D., Powles, T. J., Cauley, J. A., Norton, L., Nickelsen, T., Bjarnason, N. H., Morrow, M., et al. (1999) · JAMA · doi:10.1001/jama.281.23.2189 · Cited by 1,872
Delmas, P. D., Bjarnason, N. H., Mitlak, B. H., Ravoux, A.-C., Shah, A. S., Huster, W. J., Draper, M., & Christiansen, C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712043372301 · Cited by 1,637
Reginster, J.-Y., Minne, H. W., Sorensen, O. H., Hooper, M., Roux, C., Brandi, M. L., Lund, B., Ethgen, D., Pack, S., Roumagnac, I., et al. (2000) · Osteoporosis International · doi:10.1007/s001980050010 · Cited by 1,580
Ray, N. F., Chan, J. K., Thamer, M., & Melton, L. J. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.1.24 · Cited by 1,281
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258
Black, D. M., Greenspan, S. L., Ensrud, K. E., Palermo, L., McGowan, J. A., Lang, T. F., Garnero, P., Bouxsein, M. L., Bilezikian, J. P., & Rosen, C. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa031975 · Cited by 1,174
Self-citationChesnut, C. H., Silverman, S., Andriano, K., Genant, H., Gimona, A., Harris, S., Kiel, D., LeBoff, M., Maricic, M., Miller, P., et al. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00490-3 · Cited by 1,122
Self-citationVertebral Fractures and Mortality in Older Women: A Prospective Study
Kado, D. M. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.11.1215 · Cited by 1,039
Fracture Risk Reduction with Alendronate in Women with Osteoporosis: The Fracture Intervention Trial
Black, D. M., Thompson, D. E., Bauer, D. C., Ensrud, K., Musliner, T., Hochberg, M. C., Nevitt, M. C., Suryawanshi, S., & Cummings, S. R. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6953 · Cited by 982
The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis
Finkelstein, J. S., Hayes, A., Hunzelman, J. L., Wyland, J. J., Lee, H., & Neer, R. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035725 · Cited by 829
Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen
Lufkin, E. G., Wahner, H. W., O'Fallon, W. M., Hodgson, S. F., Kotowicz, M. A., Lane, A. W., Judd, H. L., Caplan, R. H., & Riggs, B. L. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-1-1 · Cited by 810
Self-citationOrwoll, E., Scheele, W., Paul, S., Adami, S., Syversen, U., Diez-Perez, A., Kaufman, J.-M., Clancy, A., & Gaich, G. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.1.9 · Cited by 776
Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of Estrogen
Weiss, N. S., Ure, C. L., Ballard, J. H., Williams, A. R., & Daling, J. R. (1980) · New England Journal of Medicine · doi:10.1056/nejm198011203032102 · Cited by 775
Esophagitis Associated with the Use of Alendronate
de Groen, P. C., Lubbe, D. F., Hirsch, L. J., Daifotis, A., Stephenson, W., Freedholm, D., Pryor-Tillotson, S., Seleznick, M. J., Pinkas, H., & Wang, K. K. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351403 · Cited by 764
Lindsay, R., Nieves, J., Formica, C., Henneman, E., Woelfert, L., Shen, V., Dempster, D., & Cosman, F. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02342-8 · Cited by 749
Self-citationVahle, J. L., Sato, M., Long, G. G., Young, J. K., Francis, P. C., Engelhardt, J. A., Westmore, M. S., Ma, Y. L., & Nold, J. B. (2002) · Toxicologic Pathology · doi:10.1080/01926230252929882 · Cited by 695
Cohen, S., Levy, R. M., Keller, M., Boling, E., Emkey, R. D., Greenwald, M., Zizic, T. M., Wallach, S., Sewell, K. L., Lukert, B. P., et al. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199911)42:11<2309::aid-anr8>3.0.co;2-k · Cited by 613
Pols, H. A. P., Felsenberg, D., Hanley, D. A., Štepán, J., Muñoz-Torres, M., Wilkin, T. J., Qin-sheng, G., Galich, A. M., Vandormael, K., Yates, A. J., et al. (1999) · Osteoporosis International · doi:10.1007/pl00004171 · Cited by 593
Reid, D. M., Hughes, R. A., Laan, R. F. J. M., Sacco-Gibson, N. A., Wenderoth, D. H., Adami, S., Eusebio, R. A., & Devogelaer, J.-P. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.1006 · Cited by 592
Wolff, I., van Croonenborg, J. J., Kemper, H. C. G., Kostense, P. J., & Twisk, J. W. R. (1999) · Osteoporosis International · doi:10.1007/s001980050109 · Cited by 589
Prevention of Hip Fracture in Elderly People with Use of a Hip Protector
Kannus, P., Parkkari, J., Niemi, S., Pasanen, M., Palvanen, M., Järvinen, M., & Vuori, I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432101 · Cited by 556
Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age
Hosking, D., Chilvers, C. E. D., Christiansen, C., Ravn, P., Wasnich, R., Ross, P., McClung, M., Balske, A., Thompson, D., Daley, M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802193380801 · Cited by 488
Self-citationEnsrud, K. E., Thompson, D. E., Cauley, J. A., Nevitt, M. C., Kado, D. M., Hochberg, M. C., Santora, A. C., & Black, D. M. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb02641.x · Cited by 451
Antifracture Efficacy of Antiresorptive Agents Are Related to Changes in Bone Density
Wasnich, R. D. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.1.231 · Cited by 417
Alendronate Once-Weekly Study Group, Schnitzer, T., Bone, H. G., Crepaldi, G., Adami, S., McClung, M., Kiel, D., Felsenberg, D., Recker, R. R., Tonino, R. P., et al. (2000) · Aging Clinical and Experimental Research · doi:10.1007/bf03339822 · Cited by 394
Self-citationWells, G., Tugwell, P., Shea, B., Guyatt, G., Peterson, J., Zytaruk, N., Robinson, V., Henry, D., O’Connell, D., Cranney, A., et al. (2002) · Endocrine Reviews · doi:10.1210/er.2001-5002 · Cited by 372
Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women1
Tonino, R. P., Meunier, P. J., Emkey, R., Rodriguez-Portales, J. A., Menkes, C.-J., Wasnich, R. D., Bone, H. G., Santora, A. C., Wu, M., Desai, R., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6777 · Cited by 335
Prevention of Nonvertebral Fractures by Alendronate: A Meta-analysis
Karpf, D. B. (1997) · JAMA · doi:10.1001/jama.1997.03540380073035 · Cited by 281
Ishimi, Y. (1999) · Endocrinology · doi:10.1210/en.140.4.1893 · Cited by 274
Hannon, R., Blumsohn, A., Naylor, K., & Eastell, R. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.7.1124 · Cited by 257
Cummings, S. R. (2000) · JAMA · doi:10.1001/jama.283.10.1318 · Cited by 249
Clinical Use of Biochemical Markers of Bone Remodeling: Current Status and Future Directions
Looker, A. C., Bauer, D. C., Chesnut III, C. H., Gundberg, C. M., Hochberg, M. C., Klee, G., Kleerekoper, M., Watts, N. B., & Bell, N. H. (2000) · Osteoporosis International · doi:10.1007/s001980070088 · Cited by 246
Self-citationRecker, R. R., Davies, K. M., Dowd, R. M., & Heaney, R. P. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-11-199906010-00005 · Cited by 243
Self-citationEnsrud, K. E. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.22.2617 · Cited by 220
Axial Bone Mass in Older Women
Orwoll, E. S., Bauer, D. C., Vogt, T. M., & Fox, K. M. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-2-199601150-00001 · Cited by 210
Devogelaer, J. P., Broll, H., Correa-Rotter, R., Cumming, D. C., Nagant de Deuxchaisnes, C., Geusens, P., Hosking, D., Jaeger, P., Kaufman, J. M., Leite, M., et al. (1996) · Bone · doi:10.1016/8756-3282(95)00436-x · Cited by 191
Ravn, P., Bidstrup, M., Wasnich, R. D., Davis, J. W., McClung, M. R., Balske, A., Coupland, C., Sahota, O., Kaur, A., Daley, M., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-12-199912210-00005 · Cited by 186
Self-citationEnsrud, K. E. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440430099012 · Cited by 181
Lindsay, R., Cosman, F., Lobo, R. A., Walsh, B. W., Harris, S. T., Reagan, J. E., Liss, C. L., Melton, M. E., & Byrnes, C. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.5989 · Cited by 180
Self-citationPrevention of Hip Fractures by External Hip Protectors: A Randomized Controlled Trial
van Schoor, N. M., Smit, J. H., Twisk, J. W. R., Bouter, L. M., & Lips, P. (2003) · JAMA · doi:10.1001/jama.289.15.1957 · Cited by 175
Meunier, P. J., Sebert, J.-L., Reginster, J.-Y., Briancon, D., Appelboom, T., Netter, P., Loeb, G., Rouillon, A., Barry, S., Evreux, J.-C., et al. (1998) · Osteoporosis International · doi:10.1007/s001980050041 · Cited by 168
Roux, C., Oriente, P., Laan, R., Hughes, R. A., Ittner, J., Goemaere, S., Di Munno, O., Pouillès, J. M., Horlait, S., & Cortet for the ciblos study group, B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4742 · Cited by 167
Cyclical Etidronate in the Treatment of Postmenopausal Osteoporosis
Miller, P. D., Watts, N. B., Licata, A. A., Harris, S. T., Genant, H. K., Wasnich, R. D., Ross, P. D., Jackson, R. D., Hoseyni, M. S., Schoenfeld, S., et al. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00278-7 · Cited by 153
Self-citationStock, J. L., Bell, N. H., Chesnut, C. H., Ensrud, K. E., Genant, H. K., Harris, S. T., McClung, M. R., Singer, F. R., Yood, R. A., Pryor-Tillotson, S., et al. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00130-7 · Cited by 141
Self-citationPrevention of Bone Loss with Risedronate in Glucocorticoid-Treated Rheumatoid Arthritis Patients
Eastell, R., Devogelaer, J.-P., Peel, N. F. A., Chines, A. A., Bax, D. E., Sacco-Gibson, N., Nagant de Deuxchaisnes, C., & Russell, R. G. G. (2000) · Osteoporosis International · doi:10.1007/s001980070122 · Cited by 134
BIOCHEMICAL MARKERS OF BONE TURNOVER
Garnero, P., & Delmas, P. D. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70007-4 · Cited by 131
Grainge, M. J., Coupland, C. A. C., Cliffe, S. J., Chilvers, C. E. D., & Hosking, D. J. (1998) · Osteoporosis International · doi:10.1007/s001980050075 · Cited by 108
Downs, R. W., Bell, N. H., Ettinger, M. P., Walsh, B. W., Favus, M. J., Mako, B., Wang, L., Smith, M. E., Gormley, G. J., & Melton, M. E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6606 · Cited by 107
Ravn, P., Weiss, S. R., Rodriguez-Portales, J. A., McClung, M. R., Wasnich, R. D., Gilchrist, N. L., Sambrook, P. N., Fogelman, I., Krupa, D. A., Yates, A. J. P., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6549 · Cited by 99
Self-citationTREATMENT OF OSTEOPOROSIS WITH BISPHOSPHONATES
Watts, N. B. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70014-1 · Cited by 93
Self-citationA prospective study of thiazide use and fractures in women
Feskanich, D., Willett, W. C., Stampfer, M. J., & Colditz, G. A. (1997) · Osteoporosis International · doi:10.1007/bf01623465 · Cited by 88
Lippuner, K., Hænggi, W., Birkhaeuser, M. H., Casez, J.-P., & Jaeger, P. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.5.806 · Cited by 79
Upper gastrointestinal toxicity of alendronate
Lowe, C., Depew, W. T., Vanner, S. J., Paterson, W. G., & Meddings, J. B. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01835.x · Cited by 75
Alendronate-associated esophagitis: endoscopic and pathologic features
Ribeiro, A. C., DeVault, K. R., Wolfe, J. T., & Stark, M. E. (1998) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(98)70256-1 · Cited by 71
Gennari, C., Agnusdei, D., Crepaldi, G., et al. (1998) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-199805010-00003 · Cited by 70
Gambacciani, M., Ciaponi, M., Cappagli, B., Piaggesi, L., & Genazzani, A. R. (1997) · Maturitas · doi:10.1016/s0378-5122(97)00059-5 · Cited by 64
Meunier, P. J. (1999) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1999.tb11682.x · Cited by 59
The clinical tolerability profile of alendronate.
Watts, N. B., Freedholm, D., & Daifotis, A. G. (1999) · PubMed · Cited by 56
Self-citationPavlov, P. W., Ginsburg, J., Pm, K., van der Schaaf, D. B., Prelević, G. M., & Bennink, H. J. T. C. (1999) · Gynecological Endocrinology · doi:10.3109/09513599909167560 · Cited by 44
Studd, J. W. W. (1998) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(98)00235-x · Cited by 39
Short-Term Intravenous Bisphosphonates in Prevention of Postmenopausal Bone Loss
Heikkinen, J. E., Selander, K. S., Laitinen, K., Arnala, I., & Väänänen, H. K. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.1.103 · Cited by 31
Perimenopausal bone density screening—will it help prevent osteoporosis?
Garton, M. J., Cooper, C. C., & Reid, D. M. (1997) · Maturitas · doi:10.1016/s0378-5122(96)01079-1 · Cited by 29
Therapy for Fracture Prevention
McClung, M. R. (1999) · JAMA · doi:10.1001/jama.282.7.687 · Cited by 28
Self-citationRole of oral pamidronate in preventing bone loss in postmenopausal women
Lees, B., Garland, S. W., Walton, C., Ross, D., Whitehead, M., & Stevenson, J. C. (1996) · Osteoporosis International · doi:10.1007/bf01629581 · Cited by 26
Understanding the Bone Mass Measurement Act
Watts, N. B. (1999) · Journal of Clinical Densitometry · doi:10.1385/jcd:2:3:211 · Cited by 22
Self-citationDowns, R. W., Bell, N. H., Ettinger, M. P., Walsh, B. W., Favus, M. J., Mako, B., Wang, L., Smith, M. E., Gormley, G. J., & Melton, M. E. (2000) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200010000-00020 · Cited by 18
Ipriflavone prevents the loss of bone mass in pharmacological menopause induced by GnRH-agonists
Gambacciani, M., Cappagli, B., Piaggesi, L., et al. (1997) · Calcified Tissue International · doi:10.1007/s002239900379 · Cited by 15
Cited by
Osteoporosis: now and the future
Rachner, T. D., Khosla, S., & Hofbauer, L. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62349-5 · Cited by 2,696
Acromegaly: An Endocrine Society Clinical Practice Guideline
Katznelson, L., Laws, E. R., Melmed, S., Molitch, M. E., Murad, M. H., Utz, A., & Wass, J. A. H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2700 · Cited by 1,786
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Self-citationEpidemiology, etiology, and diagnosis of osteoporosis
Lane, N. E. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.08.047 · Cited by 1,293
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Metadata
- Authors
- Hodgson, S. F., Watts, N. B., Bilezikian, J. P., Clarke, B. L., Gray, T. K., Harris, D. W., Conrad Johnston, C., Kleerekoper, M., Lindsay, R., Luckey, M. M., McClung, M. R., Nankin, H. R., Petak, S. M., Recker, R. R., Anderson, R. J., Bergman, D. A., Bloomgarden, Z. T., Dickey, R. A., Palumbo, P. J., Peters, A. L., Rettinger, H. I., Rodbard, H. W., & Rubenstein, H. A.
- Venue
- Endocrine Practice
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 9
- Issue
- 6
- Pages
- 544-564
- ISSN
- 1530-891X (ISSN-L)
- OpenAlex
- W2396798113
- Cited by
- 605
- References
- 77
- FWCI
- 36.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.